Le Lézard
Classified in: Health, Science and technology, Business
Subject: TNM

CenTrak Expands IoT Location and Sensing Services to Awarepoint Customers


NEWTOWN, Pa., July 9, 2018 /PRNewswire/ -- CenTrak announced today the transfer of select assets of Awarepoint to its subsidiary Clinical Patents LLC (CPLLC).  The transfer of assets will further expand CenTrak's market-leading IoT Location and Sensing services with the addition of Bluetooth Low Energy (BLE) sensor technology. The transfer includes over twenty patents, many which are focused on mobile device locating and enhancing the accuracy and performance of traditional BLE systems. For existing Awarepoint customers, resources are in place to offer service and support. Awarepoint engineering and technical support personnel have been hired by CPLLC to ensure continuity of support.  Awarepoint customers can speak with dedicated resources regarding conversion and upgrade options and report technical support issues.  Please visit www.centrak.com/awarepoint or call 215-860-2928 x336 for details.

Awarepoint technology has been installed in hundreds of prominent hospitals and clinics throughout North America, leveraging hundreds of thousands of IoT sensors and tags.  CenTrak now has access to key technology features, including mobile device locating to supplement CenTrak's Connecttm platform, where it can be synthesized with the other technologies CenTrak already supports, including: Wi-Fi, Second Generation Infrared (Gen2IRtm), UHF Active RFID, Low Frequency, Passive RFID, BLE and Advanced Ultrasound (IRUStm).  The combination of these technologies will further expand the breadth of use cases which can be addressed using healthcare's leading provider of Enterprise-class Location and Sensing Services.

"We are excited and hopeful that this transaction will help to further standardize quality Location and Sensory services in healthcare," said CenTrak's President and CEO, Ari Naim. "This IoT technology is improving workflow efficiencies and generating cost reductions, while enhancing patient care. Our scalable platform and vast ecosystem of Solution Providers and Systems Integrators enable customers to easily deploy the technology throughout their entire facility for maximum utility benefit."

About CenTrak
CenTrak improves healthcare operational efficiency and the quality of patient care via the industry's most robust and scalable Enterprise Location Servicestm offering. Ranked #1 as the 2018 KLAS Category Leader for Real-Time Location Systems (RTLS), CenTrak's technology supports high velocity updates and sub-room level accuracy across the entire healthcare enterprise. In its mission to transform patient care, CenTrak helps world-class healthcare facilities increase productivity, streamline workflows, drive higher patient and staff satisfaction and reduce costs. For more information, visit CenTrak.com.

CenTrak®, Enterprise Location Services, Connecttm, Gen2IRtm and IRUStm are registered trademarks of CenTrak Inc.

CONTACT:
Adam Peck
1-215-860-2928
[email protected]

SOURCE CenTrak


These press releases may also interest you

at 19:40
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

at 19:05
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

at 19:00
David J. Dykeman, co-chair of the Life Sciences & Medical...

at 18:30
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...

at 17:21
Chemistree Technology Inc. (US OTC: CHMJF) (the "Company" or "Chemistree"), is pleased to announce that the adjourned extraordinary meeting of the holders of the 10% senior unsecured convertible debentures of the Company (the "Debentures") was...

at 17:15
Summary Product: Counterfeit Viagra, 100 mg sildenafil tabletsIssue: Health products - Product safety, Unauthorized productWhat to do: Immediately stop using and safely dispose of this product. Consult your health care provider if you have taken this...



News published on and distributed by: